Work

Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications

Year: 2019

Type: erratum

Abstract: Missing Conflict of Interest DisclosureIn the original article, we neglected to include the following conflict of interest disclosure: **Patents associated with CAR design, T cell manufacturing, and delivery have been licensed by Mustang Bio., Inc., for which C.E.B. receives licensing and consulting payments.** to **Christine E. Brown**. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Source: Frontiers in Immunology

DOI: 10.3389/fimmu.2019.00780

Authors: Hamid R. Mirzaei, Analiz Rodriguez, Jennifer Shepphird, Christine E. Brown, Behnam Badie

Institutions: Tehran University of Medical Sciences, City Of Hope National Medical Center, City of Hope, Beckman Research Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,950

OpenAlex ID: W2936689176

Cites:

Cited by: 4

Related to: 10